Search Results Search Sort by RelevanceMost Recent AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940. Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Policy Forum Nov 2008 Uncertainties in the Absence of Data: Use of Pravastatin in Young Children Anna Shifrin and Darshak Sanghavi, MD The AAP’s guidelines on lipid screening for children raise concerns about the fundamental purpose of prevention and its role in balancing individual autonomy with the benefits of society at large. Virtual Mentor. 2008;10(11):747-749. doi: 10.1001/virtualmentor.2008.10.11.pfor1-0811. Case and Commentary Jan 2005 Respect for Patient Decision Making: Mr. Douglas's Choice of Treatment Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5-0501. Case and Commentary Jan 2005 Mr. Douglas's Choice of Treatment, Option Assessment Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5a-0501. Case and Commentary Jan 2005 Mr. Douglas's Choice of Treatment, Option Comparison Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5b-0501. Case and Commentary Jan 2005 Mr. Douglas's Choice of Treatment, Additional Information Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5c-0501. Medicine and Society Oct 2010 The Personal, Social, and Economic Determinants of Cardiovascular Disease Jane S. Jue, MD, MSc Personal, social, economic, and environmental factors all contribute to the increased incidence of cardiovascular disease in the United States. Virtual Mentor. 2010;12(10):812-817. doi: 10.1001/virtualmentor.2010.12.10.msoc1-1010. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940.
Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Policy Forum Nov 2008 Uncertainties in the Absence of Data: Use of Pravastatin in Young Children Anna Shifrin and Darshak Sanghavi, MD The AAP’s guidelines on lipid screening for children raise concerns about the fundamental purpose of prevention and its role in balancing individual autonomy with the benefits of society at large. Virtual Mentor. 2008;10(11):747-749. doi: 10.1001/virtualmentor.2008.10.11.pfor1-0811.
Case and Commentary Jan 2005 Respect for Patient Decision Making: Mr. Douglas's Choice of Treatment Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5-0501.
Case and Commentary Jan 2005 Mr. Douglas's Choice of Treatment, Option Assessment Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5a-0501.
Case and Commentary Jan 2005 Mr. Douglas's Choice of Treatment, Option Comparison Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5b-0501.
Case and Commentary Jan 2005 Mr. Douglas's Choice of Treatment, Additional Information Jeanne Sokolec, EdD, MSW Virtual Mentor. 2005;7(1):23-27. doi: 10.1001/virtualmentor.2005.7.1.ccas5c-0501.
Medicine and Society Oct 2010 The Personal, Social, and Economic Determinants of Cardiovascular Disease Jane S. Jue, MD, MSc Personal, social, economic, and environmental factors all contribute to the increased incidence of cardiovascular disease in the United States. Virtual Mentor. 2010;12(10):812-817. doi: 10.1001/virtualmentor.2010.12.10.msoc1-1010.